Welcome to Aetos Life Care. Looking for a reliable pharmaceutical manufacturer?

Dapagliflozin 5mg, 10mg Tablets

Dapagliflozin is an SGLT2 inhibitor that helps control Type 2 Diabetes Mellitus by promoting urinary glucose excretion. It effectively reduces blood sugar levels, lowers blood pressure, and aids in weight management.

Category:
QUICK INQUIRY NOW

Description

Mechanism of Action:

✔ Inhibits SGLT2 receptors in the kidneys, preventing glucose reabsorption and increasing glucose excretion through urine.
Reduces blood glucose levels independently of insulin action.

Indications:

✔ Type 2 Diabetes Mellitus
Adjunct to diet and exercise for better glycemic control
✔ Also beneficial for patients with heart failure and chronic kidney disease

Key Benefits:

Promotes glucose excretion, reducing blood sugar levels
Aids in weight loss and lowers blood pressure
Lowers cardiovascular and kidney disease risks

Dosage & Administration:

  • Recommended Dosage: 5 mg or 10 mg once daily, as prescribed.
  • Route of Administration: Oral
  • Food Intake: Can be taken with or without food.

Precautions & Warnings:

  • Monitor kidney function before and during treatment.
  • Increased risk of urinary tract infections and dehydration.
  • Not recommended for Type 1 diabetes or diabetic ketoacidosis.

Possible Side Effects:

  • Increased urination
  • Dehydration
  • Genital infections (rare but possible)

Storage & Packaging:

  • Store below 30°C in a cool, dry place.
  • Available in blister packs and bulk packaging.

Manufacturing & Regulatory Compliance:

Manufactured by Aetos Life Care in WHO-GMP certified facilities, ensuring compliance with EU-GMP standards.

Global Export & Supply:

Aetos Life Care exports Dapagliflozin 5 mg, 10 mg Tablets to Latin America, Africa, Asia, Europe, and CIS countries, providing high-quality diabetes management solutions worldwide.

Leading Manufacturer and Exporter of Pharmaceuticals Across Continents

Aetos Life Care is a trusted manufacturer and exporter of high-quality generic and specialty medicines, serving over 40 countries across Latin America, Africa, Asia, Europe, and the CIS region. We have a strong presence in key markets, including Iraq, Jordan, Saudi Arabia, UAE, Ukraine, Kazakhstan, Venezuela, Ecuador, and more. Backed by 15 WHO-GMP accredited facilities designed to meet EU-GMP standards, we ensure the highest quality, safety, and compliance in every product we deliver.

Iraq, Jordan, Riyadh (Saudi Arabia), Dubai (UAE)

Ukraine, Kazakhstan, Turkmenistan, Tajikistan

Venezuela, Ecuador, Peru, Paraguay, Panama, Costa Rica, El Salvador

Cameroon, South Sudan, Angola

Myanmar